Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a multi-centered, randomized, controlled study to assess the efficacy, indications
and adverse reactions of combined administration of nebulized amikacin in patients with acute
exacerbation of non-cystic fibrosis bronchiectasis and to evaluate whether inhaled
antibiotics are more likely to cause bacterial resistance.
Phase:
Phase 4
Details
Lead Sponsor:
Qilu Hospital Qilu Hospital of Shandong University